new paper in NRDD

In this piece for Nature Reviews Drug Discovery, Nick Kapolka and I discuss the druggability of the understudied GPCR, hydroxycarboxylic acid receptor 3 (HCAR3), which we recently discovered is activated by the tryptophan pathway metabolite kynurenic acid, a potent immunomodulator. The full text can be found here: https://www.nature.com/articles/d41573-020-00173-2.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s